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Bone is a dynamic tissue that is subject to the balanced processes of bone formation and bone resorption. Imbalance
can give rise to skeletal pathologies with increased bone density. In recent years, several genes underlying such
sclerosing bone disorders have been identified. The LDL receptor-related protein 5 (LRP5) gene has been shown
to be involved in both osteoporosis-pseudoglioma syndrome and the high–bone-mass phenotype and turned out
to be an important regulator of peak bone mass in vertebrates. We performed mutation analysis of the LRP5 gene
in 10 families or isolated patients with different conditions with an increased bone density, including endosteal
hyperostosis, Van Buchem disease, autosomal dominant osteosclerosis, and osteopetrosis type I. Direct sequencing
of the LRP5 gene revealed 19 sequence variants. Thirteen of these were confirmed as polymorphisms, but six novel
missense mutations (D111Y, G171R, A214T, A214V, A242T, and T253I) are most likely disease causing. Like the
previously reported mutation (G171V) that causes the high–bone-mass phenotype, all mutations are located in the
aminoterminal part of the gene, before the first epidermal growth factor–like domain. These results indicate that,
despite the different diagnoses that can be made, conditions with an increased bone density affecting mainly the
cortices of the long bones and the skull are often caused by mutations in the LRP5 gene. Functional analysis of
the effects of the various mutations will be of interest, to evaluate whether all the mutations give rise to the same
pathogenic mechanism.
Maintenance of skeletal integrity requires a dynamic bal-
ance between bone formation and bone resorption that
is fine tuned by a complex network of systemic hormones
and local factors. Imbalance can lead to an extended
number of skeletal pathologies, including the sclerosing
bone dysplasias, a heterogeneous group of disorders
with a generalized increase in skeletal mass. Some of
these sclerosing bone dysplasias have an increased tra-
becular bone density (osteosclerosis), whereas others have
a cortical bone thickening (hyperostosis) (Whyte 1999).
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Major breakthroughs have been made in recent years
toward understanding of the molecular basis of some
sclerosing disorders. Impaired bone resorption, as seen
in the various forms of osteopetrosis, can be due to mu-
tations in a subunit of the vacuolar H pump (TCIRG1
gene) (Frattini et al. 2000; Kornak et al. 2000) or to
mutations in the chloride channel CLCN7 gene (Cleiren
et al. 2001; Kornak et al. 2001). On the other hand,
increased bone formation or an imbalance between bone
formation and bone resorption can also result in scle-
rosing bone disorders. Recently, missense mutations in
the gene encoding the inorganic pyrophosphate channel
ANK (Nu¨rnberg et al. 2001; Reichenberger et al. 2001)
have been shown to cause craniometaphyseal dysplasia
(CMDD [MIM 123000]), and increased TGF-b signal-
ing (Janssens et al. 2000; Kinoshita et al. 2000) results
in Camurati-Engelmann disease (CED [MIM 131300]).
Figure 1 Photo of hard palate of a patient from family C, demonstrating the bony prominence (torus palatinus) and associated dental
alterations.
Table 1
Families or Isolated Patients with an LRP5 Mutation
Family Origin Original Diagnosis Radiological Features
A Portland Endosteal hyperostosis Cortical thickening of the long bones with no alteration in external shape, re-
markable resistance of the bone to fractures, elongated mandible, decreased
gonial angle, torus palatinus, increased bone density of the calvarium, mandi-
ble, and endosteal surface of the long bones (Beals 1976)
B Portland Endosteal hyperostosis Cortical thickening of the long bones with no alteration in external shape, re-
markable resistance of the bone to fractures, elongated mandible, decreased
gonial angle, torus palatinus, increased bone density of the calvarium, mandi-
ble, and endosteal surface of the long bones (Beals et al. 2001)
C Portland Endosteal hyperostosis Cortical thickening of the long bones with no alteration in external shape, re-
markable resistance of the bone to fractures, elongated mandible, decreased
gonial angle, torus palatinus, increased bone density of the calvarium, mandi-
ble, and endosteal surface of the long bones. (Beals et al. 2001)
D Sardinia Van Buchem disease Enlarged mandible, increased thickness of the skull and the cortices of the long
bones (Scopelliti et al. 1999)
E England Autosomal dominant osteosclerosis Enlarged mandible and an increased gonial angle, thickened cortical bone (Ren-
ton et al. 2002)
F Belgium Osteopetrosis Thickened cortical bone with no alteration in external shape, dense cranial basis
G France Osteopetrosis Diffuse osteosclerosis of the trabecular and cortical bone, osteosclerosis of the
skull with enlargement of the cranial vault
H Argentina Osteopetrosis Osteopetrosis of the cranium with loss of the diploe, enlarged mandible, increased
thickness of the cortices of long bones
I Denmark Autosomal dominant osteopetrosis
type I
Generalized sclerosis, most pronounced at the cranial vault, not associated with
an increased fracture rate (Bollerslev and Andersen 1988)
J Denmark Autosomal dominant osteopetrosis
type I
Generalized sclerosis, most pronounced at the cranial vault, not associated with
an increased fracture rate (Van Hul et al. 2002)
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Figure 2 X-ray of forearm of patient from family F, demon-
strating thickened cortical bone with no alterations in external shape.
Figure 3 Radiograph of the skull of an affect member of family
F, showing the very dense aspect of bone.
The increased bone formation in sclerosteosis (SOST
[MIM 269500]) and in Van Buchem disease (VBCH
[MIM 239100]) turned out to be due to loss-of-function
mutations of the SOST gene, most likely increasing bone
morphogenetic protein signaling (Balemans et al. 2001,
2002; Brunkow et al. 2001). Further, it was recently
shown that the gene encoding the low-density lipopro-
tein receptor–related protein 5 (LRP5) is one of the reg-
ulators of peak bone mass in vertebrates. The autosomal
recessive osteoporosis pseudoglioma syndrome (OPPG
[MIM 259770]), a disorder causing both skeletal and
eye abnormalities, is due to inactivating mutations in
the LRP5 gene (Gong et al. 2001). Besides the neonatal
blindness, children with OPPG have a very low bone
mass and are very sensitive to fractures and skeletal de-
formities. Collagen synthesis appears normal, differen-
tiating it from the severe osteogenesis imperfecta it re-
sembles. Of interest, obligate carriers of OPPGmutations
show an increased incidence for osteoporotic fractures,
indicating a dominant effect of this gene on bone mass
(Gong et al. 1996). Targeted disruption of the LRP5
gene in mice also produces osteoporosis postnatally
(Kato et al. 2002). On the other hand, in a family that
includes phenotypically normal individuals with excep-
tionally dense bones (high bone mass [HBM] [MIM
601884]), a gain-of-function mutation (G171V) in the
LRP5 gene has been described (Little et al. 2002). The
same mutation was found in another kindred with other
phenotypic abnormalities, such as torus palatinus and a
wide, deep mandible in addition to high bone density
(Boyden et al. 2002). LRP5 acts as a coreceptor for Wnt
proteins and is expressed in osteoblasts, where it is re-
quired for the osteoblast proliferation and functions in
a Cbfa1-independent manner (Kato et al. 2002). This
all illustrates that the LRP5 signaling pathway plays an
important role in the regulation of bone mass in
vertebrates.
We performed mutation analysis of the LRP5 gene in
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Figure 4 Radiograph of the skull of an affected member of fam-
ily G, demonstrating a diffuse osteosclerosis.
Figure 5 Radiograph of lumbar spine and pelvis of an affected
member of family G, demonstrating a diffuse osteosclerosis.
families or isolated patients with conditions with an in-
creased bone density (figs. 1–7; table 1), including endo-
steal hyperostosis (families A–C), Van Buchem disease
(family D), autosomal dominant osteosclerosis (family
E), and autosomal dominant osteopetrosis type I (fam-
ilies F–J). The three kindreds A (described by Beals
[1976]), B, and C (both described by Beals et al. [2001])
originate from Portland, OR, and have autosomal dom-
inant endosteal hyperostosis (MIM 144750), a rare gen-
eralized bone dysplasia. This condition is characterized
by a cortical thickening of the long bones, with no
alteration in external shape, and a remarkable resistance
of the bone to fracture. The skeleton is normal in child-
hood; the affected patients have a normal height, pro-
portion, intelligence, and longevity. Facial metamorpho-
ses occur in adolescence, as the forehead flattens, the
mandible becomes elongated, and the gonial angle de-
creases. An enlarging osseous prominence (torus pala-
tinus) develops in the hard palate, which may lead to
malocclusion or loss of teeth (fig. 1). Changes apparent
on radiographs include increased density of the calvar-
ium, mandible, and endosteal surface of the long bones.
With advancing age, the cancellous bone becomes ra-
diographically more involved with areas of increased
bone density. The clinical and radiographic features of
the affected members of families A, B, and C resemble
closely those of the kindred described by Boyden et al.
(2002), where a G171V mutation in the LRP5 gene was
identified.
At least five members from family D, originating from
Sardinia, including the mother of the reported patient,
the grandmother, and two siblings, are proven to be
affected (Scopelliti et al. 1999). They all have an osteo-
sclerosis of the skull and an enlarged mandible. The
autosomal dominant inheritance of the disease in this
family is clearly in contrast with the diagnosis of au-
tosomal recessive Van Buchem disease made elsewhere
(Scopelliti et al. 1999).
Patient E, originating from England, is a 20-year-old
woman with an enlarged mandible (Renton et al. 2002).
Histological examination showed thickened cortical
bone not involving the underlying trabeculae. She was
diagnosed with autosomal dominant osteosclerosis. The
patient’s father had an enlargedmandible, but therewere
no other clinical signs, and the radiographic appearance
of the skull was within normal limits (Renton et al.
2002).
At least three members in the Belgian family (F) have
been diagnosed with autosomal dominant osteopetrosis
type I (Van Gaal et al. 1978). The father suffers from
severe headaches, and x-rays show very dense bones of
the skull. His daughter has a very dense cranial basis
and a cortical thickening of the vertebrae and long bones
with normal development (fig. 2). The son presents with
x-rays showing a very dense aspect of bone, mainly of
the skull (fig. 3).
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Figure 6 X-ray of a femur of an affected member of family H,
demonstrating an increased thickness of the long bones and narrowing
of the medullary canals.
Figure 7 X-ray of the cervical spine of an affected member of
family H, showing an increased bone density.
Next, an affected member of the French family (G)
has an osteomyelitis of the jaw and hearing problems
because of small auditory canals. His affected brother
has the same clinical features. X-rays show a diffuse
osteosclerosis of the trabecular and cortical bone and an
osteosclerosis of the skull with enlargement of the cranial
vault (figs. 4 and 5). There is an autosomal dominant
inheritance in this family diagnosed with osteopetrosis
type I.
Patient H is a 17-year-old female from Argentina who
presents with a diagnosis of osteopetrosis. Shewas asymp-
tomatic until age 14, when she presented with a com-
plaint of mandibular pain, severe headaches, and ex-
tremity pain (figs. 6 and 7).
The patients of families I and J (Bollerslev and An-
dersen 1988; Van Hul et al. 2002), originating from the
county of Fyn in Denmark, were diagnosed with auto-
somal dominant osteopetrosis type I, on the basis of the
presence of osteosclerosis on x-rays and on bone mineral
density measurements. These families were described in
detail elsewhere (Bollerslev and Andersen 1988; VanHul
et al. 2002) and were used to localize the ADOI gene
to chromosome 11q12–13 (Van Hul et al. 2002). The
control subjects who were included in this mutation
analysis are of Belgian origin and without any indication
of abnormal bone mineral density.
The LRP5 gene contains 23 exons and spans 1100
kb. Direct sequencing of the PCR products spanning all
the exons and exon-intron boundaries (primer sequences
and conditions are available from the authors) revealed
19 sequence variants, of which 13 are probably poly-
morphisms (table 2). Eight variants in the coding region
involve third codon positions and do not introduce an
amino acid change (D111D, T534T, F549F, E644E,
N740N, D1099D, V1119V, and T1596T). This makes it
very unlikely that they have any effect on the functioning
of the protein. Three other polymorphisms do generate
an amino acid change (Q89R, V667M, and A1330V).
Two of them (V667M and A1330V) were also found in
control samples and could, therefore, not be disease-
causing variants. We could not find the Q89R variation
in 100 control samples. However, this polymorphism is
described elsewhere, with an allele frequency of 8% for
89R in the Japanese population (Okubo et al. 2002).
The two remaining polymorphisms are located in exon
1, more exactly, in the leucine stretch of the signal pep-
tide of the LRP5 protein. One variant (L20dup) is an
in-frame duplication of three nucleotides (CTG), which
results in an insertion of one leucine. In the other variant
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Table 2
Polymorphisms in the Coding Region of the LRP5 Gene
Sequence Change
Protein
Change Exon
Allele Frequency
in Controls
(%)
52-60delCTGCTGCTG L18-L20del 1 (Leu)6:1 (Leu)9:99
60-61dupCTG L20dup 1 (Leu)9:95 (Leu)10:5
266ArG Q89Ra 2 A:100 G:0
333CrT D111D 2 C:100 T:0
1602GrA T534T 8 G:100 A:0
1647CrT F549F 8 C:94 T:6
1932GrA E644E 9 G:95 A:5
1999GrA V667M 9 G:95 A:5
2268CrT N740Na 10 C:86 T:14
3297CrT D1099D 15 C:100 T:0
3357ArG V1119Va 15 A:73 G:27
3989CrT A1330Va 18 C:91 T:9
4788CrT T1596T 23 C:97 T:3
a Polymorphism identified by Okubo et al. (2002).
Figure 8 Alignment of the aminoterminal part of the LRP5 protein with its most closely related homologue, LRP6, in human, mouse,
and Xenopus. The signal peptide, one LDLR repeat with its six YWTD repeats (indicated with a line), and the following EGF repeat are shown.
The numbering of the amino acid sequence is based on the human LRP5. The positions of the six novel missense mutations are indicated with
an asterisk (*). These residues are highly conserved in human, mouse, and Xenopus LRP5 as well as in human, mouse, and Xenopus LRP6.
(L18-L20del), an inframe deletion of nine nucleotides
(CTGCTGCTG) occurred, which resulted in a deletion
of three leucines. Both variants are most likely caused
by an unequal crossover within the leucine stretch. Both
L20dup and L18-L20del are also found in control
samples (table 2), indicating that they are not disease
causing.
Recently, a gain-of-function mutation (G171V) in the
LRP5 gene was described in two kindreds with an en-
hanced bone density (Boyden et al. 2002; Little et al.
2002). The glycine at amino acid position 171 lies in
the fourth blade of the first propeller of the LRP5 pro-
tein, exactly 2 amino acids beyond the YWTD sequence,
and is highly conserved (fig. 8). It is remarkable that the
family described by Little et al. (2002) has no features
other than very dense bones, whereas patients from the
other kindred also suffer from a wide, deep mandible and
a torus palatinus. Therefore, the same mutation (G171V)
is associated with different phenotypic features in the
two families. We have now identified a new mutation
(G171R) in the Belgian family F (table 3) involving the
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Table 3
Novel Mutations in the LRP5 Gene
Mutation
Protein
Change Exon Family
331GrT D111Y 2 H
511GrC G171R 3 F
640GrA A214T 3 C
641CrT A214V 3 E
724GrA A242T 4 A B D G
758CrT T253I 4 I J
same amino acid. The clinical and radiological features
of family F closely resemble those of the family described
by Little et al. (2002), since they do not suffer from an
enlarged mandible and a torus palatinus.
Next, we identified two mutations in exon 3 changing
the same amino acid at position 214. This alanine 214
is located within the fifth YWTD repeat of the first
YWTD/EGF domain of the LRP5 protein. In family C,
a A214T missense mutation was found in the five af-
fected individuals, whereas an A214V mutation was
found in patient E. Despite the fact that family C was
diagnosed with endosteal hyperostosis and family E was
diagnosed with osteosclerosis, the clinical and radiolog-
ical features are similar.
Another mutation was found in the sixth YWTD re-
peat of the first propeller of the LRP5 protein. A CrT
transversion at cDNA position 758 resulted in a thre-
onine-to-isoleucine amino acid change (T253I) in fam-
ilies I and J. Families I and J both originate from the
county of Fyn in Denmark. Comparison elsewhere of the
haplotypes cosegregating with the disease in these families
has suggested that these families are related (Van Hul et
al. 2002). This is in line with the current finding of a
shared mutation. Further, a missense mutation (D111Y)
in exon 2 of the LRP5 gene was found in patient H.
This aspartic acid on position 111 is conserved between
the LRP5 and LRP6 proteins in human, mouse, and
Xenopus (fig. 8).
We identified another mutation (A242T) in exon 4 of
the LRP5 gene in families A, B, D, and G (table 3). This
highly conserved alanine residue is also located in the
first propeller of the LRP5 protein. Analysis of intragenic
SNPs (table 2) and of markers intragenic or close to the
LRP5 gene (D11S1917, D11S4087, D11S1337, and
D11S4187) have shown that families A, B, D, and G do
not have a common haplotype and are, therefore, not
related, which suggests that the mutations have arisen
independently (data not shown). A possible explanation
for the recurrence of this mutation might be that the
mutation is caused by a spontaneous deamination of the
cytosine being part of a CpG dinucleotide on the com-
plementary strand. This mutation is also associated with
slightly different phenotypic features, since the affected
members of families A, B, and D all have an enlarged
mandible, whereas the affected members of family G
suffer from an osteomyelitis of the jaw. We believe that
the six missense mutations described are disease causing,
as we did not find them in 100 control chromosomes;
neither did others (Boyden et al. 2002; Little et al. 2002;
Okubo et al. 2002). Moreover, the mutations involve
conserved amino acids and are all located within the
first propeller of the LRP5 protein.
Our results indicate that gain-of-function mutations
in the LRP5 gene not only cause the high–bone-mass
phenotype but are also underlying related sclerosing bone
dysplasias. Cases presenting with an autosomal domi-
nant mode of inheritance and diagnosed with osteoscle-
rosis, endosteal hyperostosis, Worth disease, or osteo-
petrosis type I turned out to have a high risk of being
caused by missense mutations in theLRP5 gene. All such
cases share an increased thickness of the skull and of
the cortices of the long bones. As already shown for the
G171V mutation, they can present either with or with-
out an enlarged mandible (Boyden et al. 2002; Little et
al. 2002). In the former case, it might be difficult to
differentiate from sclerosteosis and Van Buchem disease.
However, these conditions present with an autosomal
recessive mode of inheritance and are, in general, more
severe, causing secondary features, such as facial nerve
palsy and hearing loss. All the currently found missense
mutations are located in the aminoterminal part of the
LRP5 gene, more exactly, in exons 2, 3, and 4 encoding
the first of four propellers of the LRP5 protein. The
evolutionary conservation of the altered residues is
strong evidence of their functional importance (see fig.
8). Further, it has been shown that mutations in these
YWTD motifs of the LDL receptor cause familial hy-
percholesterolemia, which indicates that these domains
are of structural importance (Jeon et al. 2001). Exper-
imental data have shown elsewhere that the normal in-
hibition of Wnt signaling was defective in the presence
of the G171V mutation. The antagonistic protein Dick-
kopf-1 could not bind to mutated LRP5, resulting in a
constitutive activity of the Wnt signaling pathway (Boy-
den et al. 2002). Further functional experiments on the
other mutations will reveal whether the same pathogenic
mechanism is underlying the other conditions and
whether any form of genotype-phenotype correlation can
be made.
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